Skip to main content

This job has expired

You will need to login before you can apply for a job.

Scientist- Assay Development

Employer
Intellia Therapeutics
Location
Cambridge, MA, United States
Start date
Jan 14, 2021

View more

Discipline
Science/R&D, Bio-Assay Development, Biotechnology
Required Education
Doctorate/PHD/MD
Position Type
Full time
Hotbed
Genetown

Job Details

Our Mission: Developing curative genome editing treatments that can positively transform the lives of people living with severe and life-threatening diseases.

At Intellia, we are committed to solving the complex challenges of making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to create novel engineered cell therapies for immuno-oncological and autoimmune diseases.

Job Description:

Intellia is seeking a highly skilled and motivated assay development scientist to join our growing team. The primary responsibility of the Scientist will be to assist in developing bioassays/immunoassays to support various programs.

Responsibilities:
  • Design, perform, and troubleshoot immunoassays including ELISA and BLI. Familiarity with Meso Scale Discovery and ForteBio Octet is a plus
  • Responsible for generating and qualifying critical reagents for immunoassays
  • Perform and optimize in-vitro cell-based assays and functional assays
  • Interface with DNA repair group to contribute to the assay development portion of their programs
  • Participate in regular group meetings to present research and development findings
  • Order supplies and help maintain assay resources
  • Maintain a good laboratory notebook in a timely manner

Qualifications:
  • Ph.D. with1-3 years of relevant experience in biopharmaceutical industries, M.S. with 6+ years of relevant experience in biopharmaceutical industries, or B.S. with 9+ years of relevant experience in biopharmaceutical industries.
  • Demonstrated ability to develop a robust assay from conception with minimum supervision.
  • Direct experience developing and troubleshooting assays utilizing flow cytometry, ELISA, binding assays, and enzymatic assays (fluorescence, luminescence, and absorbance)
  • Competent in analyzing data with Excel worksheet and Prism
  • Demonstrated abilities to learn new skills, solve challenging scientific and technical problems, think independently, and work collaboratively in teams
  • Tissue culture experience (sterile technique, transfection, cell maintenance)


#LI-DG1

EEOC Statement: Intellia believes in a diverse environment, and is committed to equal employment opportunity for all its employees and qualified applicants. We do not discriminate in recruitment, hiring, training, promotion or any other employment practices for reasons of race, color, religion, gender, national origin, age, sexual orientation, marital or veteran status, disability, or any other legally protected status. Intellia will make reasonable accommodations for qualified individuals with known disabilities, in accordance with applicable law.

Company

Many of us pursuing work in the biotechnology industry are inspired by a loved one who is living with a disease or the loss of someone in our community. Rare genetic and oncological and immunological diseases not only affect the people living with often debilitating and life-threatening symptoms, but these disorders also significantly impact their families, friends and caregivers.
 
Our researchers work tirelessly to harness the genome editing technology CRISPR/Cas9 for human therapeutic use. Jennifer Doudna, an Intellia co-founder, and Emmanuelle Charpentier were awarded the 2020 Nobel Prize in Chemistry for their pioneering work in CRISPR. We at Intellia are humbled to have a hand in making what we believe to be medical history. As a leader in this space, we take this responsibility to patients seriously.
 
We are employing a modular genome editing platform to create diverse in vivo and ex vivo pipelines, spanning a range of therapeutic indications. Guided by this full-spectrum approach, we are committed to making CRISPR/Cas9-based medicines a reality for patients suffering from genetic diseases and to creating novel engineered cell therapies for various cancers and autoimmune diseases.

Change life stories with genome editing therapies!

Stock Symbol: NTLA

TwitterInstagram

Company info
Website
Phone
(857) 285-6200
Location
40 Erie Street
Cambridge
Massachusetts
02139
United States

Get job alerts

Create a job alert and receive personalized job recommendations straight to your inbox.

Create alert